Abiopharma

🔍 Stahl Stephanie (Director)

Company: NEWELL BRANDS INC. (NWL)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 39,325 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 39,325.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 50,552 shares of Deferred RSU Phantom Stock (Derivative)
  Date: 2026-05-07 | Code: H | shares_owned_after: 50,552.00 | Footnotes: F1, F4, F3, F5

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Newell Brands Inc. common stock.
• F2: The award shall vest in full upon the earlier of: (i) the first anniversary of the date of the grant of the award or (ii) the next annual meeting of the Company's stockholders, which is at least 50 weeks after the immediately preceding year's annual meeting of the Company's stockholders; provided the Reporting Person remains in continuous service on the Board until such vesting date.
• F3: N/A
• F4: The Reporting Person's phantom stock units will convert to shares of the Company's Common Stock on a one-for-one basis after the end of the reporting person's service on the Company's Board, in accordance with the DCP.
• F5: Represents vested awards of 49,859 RSUs granted in 2024 and 2025, pursuant to the Newell Brands Inc. 2022 Incentive Plan, which includes 30,418 RSUs that vested on May 7, 2026. The Reporting Person elected to defer settlement on the scheduled vesting date and the RSU's instead converted to an equal number of phantom stock units, in accordance with the DCP.
• F6: The report total includes 693.17 phantom stock units acquired by the Reporting Person pursuant to a dividend reinvestment feature of the DCP since the date of the last report. The additional phantom stock units acquired pursuant to the dividend reinvestment feature will be settled for cash after the end of the Reporting Person's service on the Company's Board